Pharma/Biotech - Page 1 | TalkMarkets
All Posts > Content under Pharma/Biotech
1 to 16 of 628 Posts
1 2 3 ... 40
Biden Wins Election But Trump Refuses To Concede
Article By: Alan Geik
Wednesday, November 11, 2020 12:21 PM EDT
As expected, Biden won the election but my much slimmer margins than anticipated. Complicating matters is Trump's refusal to concede.
In this article: PFE
Read
Cempra Poised To Join Antibacterial Drug Acquisition Rumor Buzz With Upcoming Data Release
Article By: Scott Matusow
Monday, November 24, 2014 12:28 PM EDT
Cempra Pharmaceuticals expects top-line data release for community acquired bacterial pneumonia by the end of Q1'15. With the very recent Tetraphase acquisition rumor buzz, Cempra is certain to join the acquisition buzz fray if its data release proves positive.
In this article: CBST, CEMP, TTPH
Read
E Shares Of Prosensa Surge 50% After Announcing It Will Be Acquired By Biomarin
Article By: Terry Chrisomalis
Monday, November 24, 2014 10:33 AM EDT
Biomarin is purchasing Prosensa for approximately $840 million.
In this article: BMRN, RNA, SRPT, RGLS
Read
Thanksgiving Top Trades Review – Using Options To Reduce Risk And Increase Profits
Article By: Phil Davis
Saturday, November 22, 2014 1:54 PM EDT
How to use stock options to both leverage AND hedge your positions to maximize your profits while minimizing your risks.
In this article: CAT, CLF, GSK, AAPL, EWJ, TZA, USO
Read
E Going Green And Saving Green
Article By: Vivian Lewis
Saturday, November 22, 2014 8:39 AM EDT
Today we consider a way to play cheap fuel prices which directly offsets one of our oil plays. Plus, we plan to take the train. And we report on global energy, pharma and food stock happenings.
In this article: AGU, CPA, EC, NBL, NOK, NVS, POT, SLB, ATONY, BRGYY, DGRLY, TKPPY, ILMN, MHG, CGG
Read
E Special Report: Benitec Biopharma Ltd.
Article By: Vivian Lewis
Thursday, November 20, 2014 8:41 AM EDT
This special report is about Benitec, a stock we recommend, after I spent the morning at its US Investor Day.
In this article: BTEBY
Read
AGIO Hits Record Level On Impressive Clinical Data For Leukemia Drug
Article By: BioMedReports
Thursday, November 20, 2014 3:21 AM EDT
Shares of Agios Pharmaceuticals Inc. posted its biggest single day rally on Wednesday since 26th September. The stock is up a whopping 15% to $96.25 after hitting an all time high of $96.88 earlier in the session.
In this article: AGIO
Read
E Merrimack Receives Fast Track For Pancreatic Cancer Drug
Article By: Terry Chrisomalis
Wednesday, November 19, 2014 4:29 PM EDT
The reason the FDA gave MACK Fast Track approval is because there are no current therapies for pancreatic cancer -- the drug meets an unmet medical need.
In this article: BAX, MACK
Read
Health Care REIT Completes HealthLease Transaction
Article By: Business Wire
Wednesday, November 19, 2014 12:00 PM EDT
Health Care REIT, Inc. announced today the completion of the previously announced acquisition of HealthLease Properties REIT (“HealthLease”).
In this article: HCN
Read
CytRx Announces Partial Clinical Hold On Main Drug' Big Buying Opportunity For Investors
Article By: Terry Chrisomalis
Tuesday, November 18, 2014 2:36 PM EDT
Aldoxorubicin receives a partial clinical hold from the FDA.
In this article: CYTR
Read
Fat Busting By Injection
Article By: IPO Candy
Tuesday, November 18, 2014 1:42 PM EDT
Neothetics is on the road now to fund the continued development of their injection-based approach to fat loss. It’s a smallish deal of $4.3M shares, with a $13-15 price range.
In this article: ZLTQ, KYTH
Read
Hot Bargains In Big Biotech
Article By: Bret Jensen
Tuesday, November 18, 2014 12:00 PM EDT
It has been an eventful year in the big pharma and biotech space, and a lot is happening in this space that biotech investors should take note of.
In this article: AGN, AVNR, REGN, AMGN, BIIB, CELG, GILD, ABBV
Read
9 Insiders Purchase Shares Of Neptune On Open Market
Article By: LastFinancier
Tuesday, November 18, 2014 9:30 AM EDT
9 insiders purchased shares of Neptune in the open market during the past week, including the Company’s interim CEO and new Chairman. With activist actions underway, can Neptune stock return to prior levels?
In this article: NEPT
Read
Work Hard And Invest In The Future: Financial Review
Article By: Marvin R Clark
Monday, November 17, 2014 8:18 PM EDT
If you thought the S&P’s furious 11% rally has been a sight to behold, you clearly weren’t paying attention to the soaring planes, trains and trucks.
In this article: FXY, IYT
Read
E Celldex Therapeutics Surges 30% After Positive Phase 2 Data In Brain Cancer
Article By: Terry Chrisomalis
Monday, November 17, 2014 5:41 PM EDT
Positive results in an interim phase 2 analysis of rindopepimut show increased survival.
In this article: CLDX
Read
E Inovio Discloses Deal Break-up Over Prostate Cancer Deal - Roche To Still Collaborate On Hepatitis B Vaccine
Article By: Terry Chrisomalis
Monday, November 17, 2014 1:24 PM EDT
Inovio Pharmaceuticals Tumbles After Roche Deal Falls Apart On Prostate Cancer Vaccine Deal
In this article: JNJ, INO, RHHBY, MDVN
Read
1 to 16 of 628 Posts
1 2 3 ... 40